A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS

A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH FIRST-LINE DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (DARA-VCD) IN AL AMYLOIDOSIS

Case Report: Systemic amyloidosis results from the production of misfolded immunoglobulin light chains by monoclonal CD38+ plasma cells. These misfolded light chains form amyloid fibrils, which accumulate in various tissues and cause organ damage. Following the results of the Phase 3 ANDROMEDA study...

Full description

Saved in:
Bibliographic Details
Main Authors: Metban Mastanzade, Meryem Merve Ören Çelik, Simge Erdem, Mustafa Murat Özbalak, İpek Yönal Hindilerden, Mustafa Nuri Yenerel, Sevgi Kalayoğlu Beşışık
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924028517
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2531137924028517

Similar Items